SBME Research Seminar: Multi-pronged CAR-T Cells for Cancer Therapy – Dr. Yvonne Chen

SBME Symposium 2024

Join us and our outstanding community of faculty, trainees, industry and hospital partners, and students as we continue to define the future of health and healthcare at our annual Symposium. • Learn from peers making an impact in the biomedical engineering field. • Discover the latest research.

SBME Symposium 2024


Loading Events

« All Events

SBME Research Seminar: Multi-pronged CAR-T Cells for Cancer Therapy – Dr. Yvonne Chen

October 24 @ 11:00 am - 12:00 pm PDT

SBME Research Seminar: Multi-pronged CAR-T Cells for Cancer Therapy – Dr. Yvonne Chen
Seminar Abstract:
The adoptive transfer of T cells expressing chimeric antigen receptors (CARs) has demonstrated robust efficacy in the treatment of advanced hematological malignancies. However, challenges such as antigen escape and immunosuppression limit the long-term efficacy of adoptive T-cell therapy, particularly for solid tumors. Here, I will discuss the development of next-generation T cells that can target multiple cancer antigens, modify the tumor microenvironment, and/or engage endogenous immunity to overcome tumor-defense mechanisms. This presentation will highlight the potential of synthetic biology in generating novel mammalian cell systems with multifunctional outputs for therapeutic applications.
Dr. Yvonne Chen Biography:
Dr. Yvonne Chen is a Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles. She is also a faculty, by courtesy, in the Department of Chemical and Biomolecular Engineering. Yvonne is the co-director of the Tumor Immunology program in the Jonsson Comprehensive Cancer Center at UCLA, and a member researcher of the Parker Institute for Cancer Immunotherapy. Dr. Chen received her B.S. in Chemical Engineering from Stanford University and her Ph.D. in Chemical Engineering from the California Institute of Technology. She received postdoctoral training at the Seattle Children’s Research Institute, and in the Department of Systems Biology at Harvard Medical School. Prior to joining UCLA in 2013, she was a Junior Fellow in the Harvard Society of Fellows. The Chen Laboratory applies synthetic biology and biomolecular engineering techniques to the development of novel mammalian-cell systems for clinical use, and Dr. Chen led the first investigator-initiated clinical trial on CAR-T cell therapy at UCLA. The Chen Lab’s work on engineering next-generation T-cell therapies for cancer has been recognized by the NIH Director’s Early Independence Award, the NSF CAREER Award, the Hellman Fellowship, the ACGT Young Investigator Award in Cell and Gene Therapy for Cancer, the Mark Foundation Emerging Leader Award, and the Cancer Research Institute Lloyd J. Old STAR Award.


October 24
11:00 am - 12:00 pm PDT
Event Categories:


Jocelyn McKay